Brain function analysis company Brain Resource (ASX:BRC) said a recently contracted US client has gone live with its web consumer product MyBrainSolutions.
AstraZeneca Pharmaceuticals has launched MyBrainSolutions – an online brain training suite of tools – for 4,000 of its employees, Brain Resource said.
The client is the first employer Brain Resource has contracted with directly, improving its revenue share for the deal, the company said. BRC shares were unchanged on Wednesday at $0.350.
Join the CIO Australia group on LinkedIn. The group is open to CIOs, IT Directors, COOs, CTOs and senior IT managers.